Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care u...
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study
About this item
Full title
Author / Creator
Pugin, Jérôme , Daix, Thomas , Pagani, Jean-Luc , Morri, Davide , Giacomucci, Angelo , Dequin, Pierre-François , Guitton, Christophe , Que, Yok-Ai , Zani, Gianluca , Brealey, David , Lepape, Alain , Creagh-Brown, Ben , Wyncoll, Duncan , Silengo, Daniela , Irincheeva, Irina , Girard, Laurie , Rebeaud, Fabien , Maerki, Iwan , Eggimann, Philippe and François, Bruno
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The early recognition and management of sepsis improves outcomes. Biomarkers may help in identifying earlier sub-clinical signs of sepsis. We explored the potential of serial measurements of C-reactive protein (CRP), procalcitonin (PCT) and pancreatic stone protein (PSP) for the early recognition of sepsis in patients hospitalized in the intensive care unit (ICU).
This was a multicentric international prospective observational clinical study conducted in 14 ICUs in France, Switzerland, Italy, and the United Kingdom. Adult ICU patients at risk of nosocomial sepsis were included. A biomarker-blinded adjudication committee identified sepsis events and the days on which they began. The association of clinical sepsis diagnoses with the trajectories of PSP, CRP, and PCT in the 3 days preceding these diagnoses of sepsis were tested for markers of early sepsis detection. The performance of the biomarkers in sepsis diagnosis was assessed by receiver operating characteristic (ROC) analysis.
Of the 243 patients included, 53 developed nosocomial sepsis after a median of 6 days (interquartile range, 3-8 days). Clinical sepsis diagnosis was associated with an increase in biomarkers value over the 3 days preceding this diagnosis [PSP (p = 0.003), PCT (p = 0.025) and CRP (p = 0.009)]. PSP started to increase 5 days before the clinical diagnosis of sepsis, PCT 3 and CRP 2 days, respectively. The area under the ROC curve at the time of clinical sepsis was similar for all markers (PSP, 0.75; CRP, 0.77; PCT, 0.75).
While the diagnostic accuracy of PSP, CRP and PCT for sepsis were similar in this cohort, serial PSP measurement demonstrated an increase of this marker the days preceding the onset of signs necessary to clinical diagnose sepsis. This observation justifies further evaluation of the potential clinical benefit of serial PSP measurement in the management of critically ill patients developing nosocomial sepsis. Trial registration The study has been registered at ClinicalTrials.gov (no. NCT03474809), on March 16, 2018. https://www.clinicaltrials.gov/ct2/show/NCT03474809?term=NCT03474809&draw=2&rank=1 ....
Alternative Titles
Full title
Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study
Authors, Artists and Contributors
Author / Creator
Daix, Thomas
Pagani, Jean-Luc
Morri, Davide
Giacomucci, Angelo
Dequin, Pierre-François
Guitton, Christophe
Que, Yok-Ai
Zani, Gianluca
Brealey, David
Lepape, Alain
Creagh-Brown, Ben
Wyncoll, Duncan
Silengo, Daniela
Irincheeva, Irina
Girard, Laurie
Rebeaud, Fabien
Maerki, Iwan
Eggimann, Philippe
François, Bruno
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7b50d053f7a7480581bd03e45600754d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b50d053f7a7480581bd03e45600754d
Other Identifiers
ISSN
1364-8535
E-ISSN
1466-609X,1364-8535,1366-609X
DOI
10.1186/s13054-021-03576-8